Skip to main content
Top
Published in: Dermatology and Therapy 1/2013

Open Access 01-06-2013 | Original Research

A New Minimally Invasive Mesotherapy Technique for Facial Rejuvenation

Authors: Antonella Savoia, Simone Landi, Alfonso Baldi

Published in: Dermatology and Therapy | Issue 1/2013

Login to get access

Abstract

Introduction

This study describes a pivotal clinical trial of a new minimally invasive mesotherapy technique for facial rejuvenation.

Methods

The authors utilized two formulations: formulation A with hyaluronic acid, vitamins, amino acids, minerals, coenzymes, and antioxidant substances; formulation B with hyaluronic acid and idebenone. Fifty participants were enrolled in the study and divided in two groups. Group 1 (50–65 years) treated with formulation A. Group 2 (35–50 years) treated with formulation B. The groups underwent four sessions of mesotherapy involving multiple injections. Treatment was conducted at 15 day intervals. All participants had pre- and posttreatment photographs. Punch biopsies were taken from randomly selected participants, baseline and after 6 weeks, and stained for interleukin (IL)-6, IL-1β, matrix metalloproteinase (MMP)-1, and collagen 1. Clinical evaluation was based on the Global Aesthetic Scale (GAIS) and on the Wrinkle Severity Rating Scale (WSRS).

Results

The results produced were statistically analyzed and resulted in a significant and long-lasting effect on facial rejuvenation. Evaluation of photographs at 0, 1, and 2 months revealed significant clinical improvement: brightness, texture, and firmness of the skin. The analysis of the GAIS and WSRS scores in the two groups demonstrated statistically significant results after 2 months. The biopsies taken from randomly selected participants at baseline and after 3 months showed a decrease in IL-1β, IL-6, and MMP1, and an increase in collagen 1.

Conclusion

The new minimally invasive mesotherapy technique described can improve the clinical appearance of the skin in different age groups.
Literature
1.
go back to reference Buck DW, Alam M, Kim JYS. Injectable fillers for facial rejuvenation: a review. J Plast Reconstr Aesth Surg. 2009;62:11–8.CrossRef Buck DW, Alam M, Kim JYS. Injectable fillers for facial rejuvenation: a review. J Plast Reconstr Aesth Surg. 2009;62:11–8.CrossRef
2.
go back to reference Oringer JS, Kang S, Johnson TM, et al. Connective tissue remodeling induced by carbon dioxide laser resurfacing of photodamaged human skin. Arch Dermatol. 2004;140:1326–32.CrossRef Oringer JS, Kang S, Johnson TM, et al. Connective tissue remodeling induced by carbon dioxide laser resurfacing of photodamaged human skin. Arch Dermatol. 2004;140:1326–32.CrossRef
3.
go back to reference Tan WQ, Gao ZJ, Xu JH, et al. Inhibiting scar formation in vitro and in vivo by adenovirus-mediated mutant Smad4: a preliminary report. Exp Dermatol. 2011;20:119–24.PubMedCrossRef Tan WQ, Gao ZJ, Xu JH, et al. Inhibiting scar formation in vitro and in vivo by adenovirus-mediated mutant Smad4: a preliminary report. Exp Dermatol. 2011;20:119–24.PubMedCrossRef
4.
go back to reference Pistor M. What is mesotherapy? Chin Dent Fr. 1976;46:59–60. Pistor M. What is mesotherapy? Chin Dent Fr. 1976;46:59–60.
5.
go back to reference Galadari H, Al Faresi F. Mesotherapy. Skinmed 2011;9:342–3. Galadari H, Al Faresi F. Mesotherapy. Skinmed 2011;9:342–3.
6.
go back to reference Lacarrubba F, Tedeschi A, Nardone B, et al. Mesotherapy for skin rejuvenation: assessment of the subepidermal low-echogenic band by ultrasound evaluation with cross-sectional B-mode scanning. Dermatol Ther. 2008;21(Suppl. 3):S1–5.PubMedCrossRef Lacarrubba F, Tedeschi A, Nardone B, et al. Mesotherapy for skin rejuvenation: assessment of the subepidermal low-echogenic band by ultrasound evaluation with cross-sectional B-mode scanning. Dermatol Ther. 2008;21(Suppl. 3):S1–5.PubMedCrossRef
7.
go back to reference Iorizzo M, De Padova MP, Tosti A. Biorejuvenation: theory and practice. Clin Dermatol. 2008;26:177–81.PubMedCrossRef Iorizzo M, De Padova MP, Tosti A. Biorejuvenation: theory and practice. Clin Dermatol. 2008;26:177–81.PubMedCrossRef
8.
go back to reference Tammi MI, Day AJ, Turley EA. Hyaluronan and homeostasis: a balancing act. J Bio Chem. 2002;277:4581–4.CrossRef Tammi MI, Day AJ, Turley EA. Hyaluronan and homeostasis: a balancing act. J Bio Chem. 2002;277:4581–4.CrossRef
9.
go back to reference Yoneda M, Shimizu S, Nishi Y, et al. Hyaluronic acid-dependent change in the extracellular matrix of mouse dermal fibroblasts that is conducive to cell proliferation. J Cell Sci. 1988;90:275–86.PubMed Yoneda M, Shimizu S, Nishi Y, et al. Hyaluronic acid-dependent change in the extracellular matrix of mouse dermal fibroblasts that is conducive to cell proliferation. J Cell Sci. 1988;90:275–86.PubMed
10.
go back to reference Gao F, Liu Y, He Y, et al. Hyaluronan oligosaccharides promote excisional wound healing through enhanced angiogenesis. Matrix Biol. 2010;29:107–16.PubMedCrossRef Gao F, Liu Y, He Y, et al. Hyaluronan oligosaccharides promote excisional wound healing through enhanced angiogenesis. Matrix Biol. 2010;29:107–16.PubMedCrossRef
11.
go back to reference Greesin J C, Hendricks L J, Falkenstein PA, et al. Regulation of collagen synthesis by ascorbic acid: characterization of the role of ascorbate-stimulated lipid peroxidation. Arch Biochem Biophys. 1991;290:127–32. Greesin J C, Hendricks L J, Falkenstein PA, et al. Regulation of collagen synthesis by ascorbic acid: characterization of the role of ascorbate-stimulated lipid peroxidation. Arch Biochem Biophys. 1991;290:127–32.
12.
go back to reference Fisher GJ, Kang S, Varani J, et al. Mechanisms of photoaging and chronological skin aging. Arch Dermatol. 2002;138:1462–70.PubMedCrossRef Fisher GJ, Kang S, Varani J, et al. Mechanisms of photoaging and chronological skin aging. Arch Dermatol. 2002;138:1462–70.PubMedCrossRef
13.
go back to reference Kligman LH. Photoaging. Manifestations, prevention, and treatment. Clin Geriatr Med. 1989;5:235–51.PubMed Kligman LH. Photoaging. Manifestations, prevention, and treatment. Clin Geriatr Med. 1989;5:235–51.PubMed
14.
15.
go back to reference Sjerobabski Masnec I, Poduje S. Photoaging. Coll Antropol. 2008;32:177–80. Sjerobabski Masnec I, Poduje S. Photoaging. Coll Antropol. 2008;32:177–80.
16.
go back to reference Warren R, Gartstein V, Klingman A, Montagna W, Allendorf RA, Ridder GM. Age, sunlight, and facial skin: a histologic and quantitative study. J Am Acad Dermatol. 1991;25:751–60.PubMedCrossRef Warren R, Gartstein V, Klingman A, Montagna W, Allendorf RA, Ridder GM. Age, sunlight, and facial skin: a histologic and quantitative study. J Am Acad Dermatol. 1991;25:751–60.PubMedCrossRef
17.
go back to reference Varani J, Dame MK, Rittie L, et al. Decreased collagen production in chronologically aged skin: role of age-dependent alteration in fibroblast function and defective mechanical stimulation. Am J Pathol. 2006;186:1861–8.CrossRef Varani J, Dame MK, Rittie L, et al. Decreased collagen production in chronologically aged skin: role of age-dependent alteration in fibroblast function and defective mechanical stimulation. Am J Pathol. 2006;186:1861–8.CrossRef
18.
go back to reference Fisher A, Morley JE. Anti-aging and complementary therapies. In: Landefeld C, Palmer R, Johnson MA, Johnston C, Lyons W, editors. Current geriatric diagnosis and treatment. New York: Lange Medical Books/McGraw-Hill; 2004. p. 468–81. Fisher A, Morley JE. Anti-aging and complementary therapies. In: Landefeld C, Palmer R, Johnson MA, Johnston C, Lyons W, editors. Current geriatric diagnosis and treatment. New York: Lange Medical Books/McGraw-Hill; 2004. p. 468–81.
19.
go back to reference Atiyeh BS, Ibrahim AE, Dibo SA. Cosmetic mesotherapy: between scientific evidence, science fiction, and lucrative business. Aesthet Plast Surg. 2008;32:842–9.CrossRef Atiyeh BS, Ibrahim AE, Dibo SA. Cosmetic mesotherapy: between scientific evidence, science fiction, and lucrative business. Aesthet Plast Surg. 2008;32:842–9.CrossRef
20.
go back to reference Mc Daniel DH, Neudecker BA, DiNardo JC, Lewis JA 2nd, Mailbach HI. Clinical efficacy assessment in photodamaged skin of 0.5% and 1.0% idebenone. J Cosmet Dermatol. 2005;4:167–73. Mc Daniel DH, Neudecker BA, DiNardo JC, Lewis JA 2nd, Mailbach HI. Clinical efficacy assessment in photodamaged skin of 0.5% and 1.0% idebenone. J Cosmet Dermatol. 2005;4:167–73.
21.
go back to reference Kamel NS, Gammack J, Cepeda O, Flaherty JH. Antioxydants and hormones as antiaging terapies: high hopes, disappointing results. Cleve Clin J. 2006;73:1049–56.CrossRef Kamel NS, Gammack J, Cepeda O, Flaherty JH. Antioxydants and hormones as antiaging terapies: high hopes, disappointing results. Cleve Clin J. 2006;73:1049–56.CrossRef
22.
go back to reference Crane FL. Biochemical function of coenzymes Q10. J Am Coll Nutr. 2001;20:591–8. Crane FL. Biochemical function of coenzymes Q10. J Am Coll Nutr. 2001;20:591–8.
23.
go back to reference Dallner G, Sinderlar PJ. Regulation of ubiquinone metabolism. Free Radic Biol Med. 2000;29:285–94.PubMedCrossRef Dallner G, Sinderlar PJ. Regulation of ubiquinone metabolism. Free Radic Biol Med. 2000;29:285–94.PubMedCrossRef
24.
go back to reference Wieland E, Schutz E, Armstrong VW, Kuthe F, Heller C, Oellerich M. Idebenone protects hepatic microsomes against oxygen radical-mediated damage in organ preservation solutions. Transplantation. 1995;60:444–51.PubMedCrossRef Wieland E, Schutz E, Armstrong VW, Kuthe F, Heller C, Oellerich M. Idebenone protects hepatic microsomes against oxygen radical-mediated damage in organ preservation solutions. Transplantation. 1995;60:444–51.PubMedCrossRef
25.
go back to reference McDaniel DH, Neudecker BA, DiNardo JC, Lewis JA 2nd. Maibach HI. Idebenone: a new antioxidant—Part I. Relative assessment of oxidative stress protection capacity compared to commonly known antioxidants. J Cosmet Dermatol. 2005;4:10–7.PubMedCrossRef McDaniel DH, Neudecker BA, DiNardo JC, Lewis JA 2nd. Maibach HI. Idebenone: a new antioxidant—Part I. Relative assessment of oxidative stress protection capacity compared to commonly known antioxidants. J Cosmet Dermatol. 2005;4:10–7.PubMedCrossRef
Metadata
Title
A New Minimally Invasive Mesotherapy Technique for Facial Rejuvenation
Authors
Antonella Savoia
Simone Landi
Alfonso Baldi
Publication date
01-06-2013
Publisher
Springer Healthcare
Published in
Dermatology and Therapy / Issue 1/2013
Print ISSN: 2193-8210
Electronic ISSN: 2190-9172
DOI
https://doi.org/10.1007/s13555-012-0018-2

Other articles of this Issue 1/2013

Dermatology and Therapy 1/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.